title: Phase II trials of idarubicin, a new anthracycline.
authors.affiliation: Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Rosso
authors.forename: A
authors.initials: A
authors.lastname: Ardizzoni
authors.forename: P
authors.initials: P
authors.lastname: Conte
authors.forename: V
authors.initials: V
authors.lastname: Fusco
authors.forename: M
authors.initials: M
authors.lastname: Gulisano
authors.forename: R
authors.initials: R
authors.lastname: Lionetto
authors.forename: P
authors.initials: P
authors.lastname: Pronzato
authors.forename: L
authors.initials: L
authors.lastname: Repetto
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use / Q000633:toxicity*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D015255:Idarubicin